Background and rationale
Alzheimer’s disease is characterized by the excessive deposition of fibrillar amyloid-β (Aβ) peptides, amyloid plaques (AP), cerebral amyloid angiopathy (CAA), and neurofibrillary tangles (NFT) that are primarily made up of tau (τ) protein. The copious amount of these lesions supports the amyloid cascade hypothesis as the major causative incident in the development of AD (Roher, et al., 2013). The amyloid cascade hypothesis states that Alzheimer’s …show more content…
Levels of tau and Aβ peptides in cerebrospinal fluid (CSF) are markers that are currently being used in detecting AD. The issue with this detection method lies in the utilization of CSF. CSF presents very little correlation between Aβ peptide levels and the severity of the disease (Leung, et al., 2013). Other protein-based biomarkers have been used also, but with little success. Utilizing Aβ peptides as potential biomarkers may allow for precise detection of AD and for understanding the severity of the disease in each affected person. In order to establish this avenue of treatment, the use of nanotechnology is